Ioannis Missitzis

705 total citations
25 papers, 581 citations indexed

About

Ioannis Missitzis is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ioannis Missitzis has authored 25 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Ioannis Missitzis's work include Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (7 papers) and T-cell and B-cell Immunology (7 papers). Ioannis Missitzis is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (7 papers) and T-cell and B-cell Immunology (7 papers). Ioannis Missitzis collaborates with scholars based in Greece, United States and Germany. Ioannis Missitzis's co-authors include Constantin N. Baxevanis, Michael Papamichail, Angelos D. Gritzapis, Alexandros Ardavanis, Andreas Scorilas, George J. Reclos, George P. Stathopoulos, Nikolaos G. Papadopoulos, George Dedoussis and Kleita Michaelidou and has published in prestigious journals such as The Journal of Immunology, Cancer and Clinical Cancer Research.

In The Last Decade

Ioannis Missitzis

25 papers receiving 563 citations

Peers

Countries citing papers authored by Ioannis Missitzis

Since Specialization

Citations

This map shows the geographic impact of Ioannis Missitzis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioannis Missitzis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioannis Missitzis more than expected).

Fields of papers citing papers by Ioannis Missitzis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ioannis Missitzis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioannis Missitzis. The network helps show where Ioannis Missitzis may publish in the future.

Co-authorship network of co-authors of Ioannis Missitzis

This figure shows the co-authorship network connecting the top 25 collaborators of Ioannis Missitzis. A scholar is included among the top collaborators of Ioannis Missitzis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioannis Missitzis. Ioannis Missitzis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term culture of patient-derived mammary organoids in non-biogenic electrospun scaffolds for identifying metalloprotein and motor protein activities in aging and senescence 2024 ·Advances in protein chemistry and structural biology ·(unknown), Iriczalli Cruz‐Maya, (unknown), (unknown), (unknown), Paride Pelucchi, Elena Angeli, Patrizia Guida, Arianna Consiglio, Giorgio Grillo, (unknown), Angelos D. Gritzapis, (unknown), Ioannis Missitzis, Martin Götte, (unknown), James Kehler, (unknown), Vincenzo Guarino, Luciano Milanesi	2
2	Fibroadenoma Arising in Axillary Ectopic Breast Tissue. A Diagnostic Challenge 2023 ·Cureus ·Nektarios Koufopoulos, (unknown), Ioannis Boutas, (unknown), (unknown), (unknown), Christos Kittas, Ioannis Missitzis	1
3	Matrix-producing Breast Carcinoma: A Rare Subtype of Metaplastic Breast Carcinoma 2019 ·Cureus ·Nektarios Koufopoulos, Stefania Kokkali, (unknown), (unknown), Ioannis Missitzis	13
4	Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients 2018 ·Clinical and Experimental Medicine ·(unknown), Kleita Michaelidou, Konstantinos Mavridis, Ioannis Missitzis, Alexandros Ardavanis, John Grınıatsos, Andreas Scorilas	12
5	Psychosocial Adjustment to Illness Scale: Factor structure, reliability, and validity assessment in a sample of Greek breast cancer patients 2016 ·Women & Health ·(unknown), Fotios Anagnostopoulos, Ioannis Missitzis	16
6	BCL2L12: A promising molecular prognostic biomarker in breast cancer 2014 ·Clinical Biochemistry ·Alexandros Tzovaras, (unknown), Kleita Michaelidou, George Zografos, Ioannis Missitzis, Alexandros Ardavanis, Andreas Scorilas	18
7	The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression 2013 ·International Journal of Oncology ·Kleita Michaelidou, Alexandros Tzovaras, Ioannis Missitzis, Alexandros Ardavanis, Andreas Scorilas	64
8	Identification of novel breast cancer‐associated transcripts by uniGene database mining and gene expression analysis in normal and malignant cells 2012 ·Genes Chromosomes and Cancer ·(unknown), (unknown), Des G. Powe, Geng Li, Amanda K. Miles, David C. Hughes, Graham Ball, Ian O. Ellis, Angelos D. Gritzapis, Ioannis Missitzis, Stéphanie McArdle, Robert C. Rees	1
9	Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer 2010 ·Journal of Cancer Research and Clinical Oncology ·Panteleimon Kountourakis, Ioannis Missitzis, (unknown), (unknown), (unknown), Niki Arnogiannaki, (unknown), Anastasia Sotiropoulou, Alexandros Ardavanis	2
10	Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy 2009 ·Cancer Immunology Immunotherapy ·(unknown), Angelos D. Gritzapis, Sonia A. Perez, Nikolaos Tsavaris, Ioannis Missitzis, Avgi Mamalaki, Michael Papamichail, Constantin N. Baxevanis	9
11	Identification of a Novel Immunogenic HLA-A0201-Binding Epitope of HER-2/ neu* with Potent Antitumor Properties 2008 ·The Journal of Immunology ·Angelos D. Gritzapis, Ioannis F. Voutsas, (unknown), Nikolaos Tsavaris, Ioannis Missitzis, Panagiota A. Sotiropoulou, Sonia A. Perez, Michael Papamichail, Constantin N. Baxevanis	27
12	Natural CD8 + T-cell responses against MHC class I epitopes of the HER-2/ neu oncoprotein in patients with epithelial tumors 2003 ·Cancer Immunology Immunotherapy ·Panagiota A. Sotiropoulou, Sonia A. Perez, (unknown), Hartmut Echner, Ioannis Missitzis, Nick B. Tsavaris, Michael Papamichail, Constantin N. Baxevanis	34
13	Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours 2003 ·British Journal of Cancer ·P Sotiropoulou, Sonia A. Perez, Eleni G. Iliopoulou, Ioannis Missitzis, Verena Voelter, Hartmut Echner, Constantin N. Baxevanis, Michail Papamichail	28
14	Quantitative Fluorescence Cytometric Measurement of Estrogen and Progesterone Receptors: Correlation with the Hormone Binding Assay 2003 ·Breast Cancer Research and Treatment ·Angelos D. Gritzapis, Constantin N. Baxevanis, Ioannis Missitzis, Efrosini S. Katsanou, Μichael N. Alexis, (unknown), Michael Papamichail	26
15	Synergy between interleukin-2 and prothymosin ? for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas 2000 ·Cancer Immunology Immunotherapy ·Ioannis F. Voutsas, Constantin N. Baxevanis, Angelos D. Gritzapis, Ioannis Missitzis, G. Stathopoulos, (unknown), (unknown), Wolfgang Voelter, Michael Papamichail	19
16	Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes 1997 ·British Journal of Cancer ·(unknown), (unknown), (unknown), G. Spanakos, Christine‐Ivy Liacos, Ioannis Missitzis, (unknown), Michael Papamichail	7
17	Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage–colony stimulating factor 1995 ·Cancer ·Constantin N. Baxevanis, George Dedoussis, Nikolaos G. Papadopoulos, Ioannis Missitzis, (unknown), George P. Stathopoulos, (unknown)	25
18	Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer 1994 ·Cancer ·Constantin N. Baxevanis, George Dedoussis, Nikolaos G. Papadopoulos, Ioannis Missitzis, George P. Stathopoulos, Michael Papamichail	89
19	Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer 1993 ·Cancer ·Constantin N. Baxevanis, George J. Reclos, Angelos D. Gritzapis, (unknown), Ioannis Missitzis, Michael Papamichail	96
20	Monocyte disorders associated with T cell defects in patients with solid tumors. 1992 ·PubMed ·(unknown), George J. Reclos, Constantin N. Baxevanis, Angelos D. Gritzapis, (unknown), Nikolaos Panagiotopoulos, Stelios Fotiou, Ioannis Missitzis, (unknown), Michael Papamichail	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact